# A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

> **NCT01545440** · PHASE2 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 258 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** lebrikizumab
- **DRUG:** lebrikizumab
- **DRUG:** lebrikizumab
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01545440
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-07
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01545440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01545440, "A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01545440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*